je.st
news
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe
2014-01-04 07:51:40| Biotech - Topix.net
NPS Pharmaceuticals, Inc. , a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.
Tags: europe
drug
receives
designation
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||